|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
EUCTR |
|
Last refreshed on:
|
19 March 2012 |
|
Main ID: |
EUCTR2004-000822-58-IT |
|
Date of registration:
|
15/09/2004 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
A double-blind, randomized study of clopidogrel 75 mg/d vs placebo,
on a background of ASA 75-100 mg/d,
in peripheral arterial disease (PAD) patients receiving a unilateral below knee bypass graft.
The CASPAR 2004 study
(Clopidogrel and Acetyl salicylic acid in bypass Surgery for Peripheral ARterial disease)
|
|
Scientific title:
|
A double-blind, randomized study of clopidogrel 75 mg/d vs placebo,
on a background of ASA 75-100 mg/d,
in peripheral arterial disease (PAD) patients receiving a unilateral below knee bypass graft.
The CASPAR 2004 study
(Clopidogrel and Acetyl salicylic acid in bypass Surgery for Peripheral ARterial disease) |
|
Date of first enrolment:
|
04/10/2004 |
|
Target sample size:
|
|
|
Recruitment status: |
Not Recruiting |
|
URL:
|
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-000822-58 |
|
Study type:
|
Interventional clinical trial of medicinal product |
|
Study design:
|
Controlled: yes
Randomised: yes
Open:
Single blind:
Double blind:
Parallel group:
Cross over:
Other:
If controlled, specify comparator, Other Medicinial Product:
Placebo:
Other:
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Finland
|
Hungary
|
Italy
|
Spain
|
Sweden
| | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
|
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion criteria:
Age minimum:
Age maximum:
Gender:
Female: yes
Male: yes
|
|
Health Condition(s) or Problem(s) studied
|
Treatment of patients with peripheral arterial disease (PAD),already treated with ASA 75-100 mg/d,receiving a unilateral below knee bypass graft.
MedDRA version: 6.1
Level: PT
Classification code 10003604
|
|
Intervention(s)
|
Trade Name: Clopidogrel
Product Name: clopidogrel
Product Code: NA
Pharmaceutical Form: Tablet
INN or Proposed INN: clopidogrel
CAS Number: 113665-84-2
Current Sponsor code: SR25990C
Concentration unit: mg milligram(s)
Concentration type: equal
Concentration number: 75-
|
|
Primary Outcome(s)
|
|
Primary end point(s):
|
|
Main Objective:
|
|
Secondary Objective:
|
|
Secondary ID(s)
|
|
C9253
|
|
2004-000822-58-SE
|
|
Source(s) of Monetary Support
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|